摘要
目的观察黄芪注射液(Astragalus membranaceus injection,AMI)对放、化疗因素所致骨髓抑制性贫血小鼠造血的影响,并探讨其可能的机制。方法:采用Co^(60)照射、注射环磷酰胺、氯霉素复合造模建立贫血小鼠模型,并将动物随机分为三组:AMI给药组Ⅰ、Ⅱ和对照组,分别腹腔注射AMI[500 mg/kg、1000 mg/kg]或等量生理盐水,第7日全自动血球仪检测外周血和骨髓有核细胞,并应用免疫组化和造血祖细胞体外培养技术,检测骨髓有核细胞BcL-XL和BcL-2蛋白的表达及进行三系造血祖细胞集落计数。结果:AMI给药组Ⅰ的RBC、HB、PLT(P<0.05)和BM(P<0.01)明显高于贫血对照组;同时给药组Ⅰ的CFU-E、BFU-E、CFU-Meg和骨髓有核细胞抗凋亡蛋白BcL-XL 的表达也明显高于贫血对照组(P<0.05或P<0.01).给药组Ⅱ的CFU-E和骨髓有核细胞抗凋亡蛋白BcL-XL的表达也高于贫血对照组(P<0.05)。结论:黄芪注射液可以通过上调抗凋亡蛋白BcL-XL表达减轻骨髓有核细胞的凋亡,并促进红系、巨核造血。
Objective: To investigate the effect of AMI on hematopoiesis in anemic mice and explore the possible mechanisms. Methods: Anemic mice model resulted from myelosuppression by irradiation and cytotoxic chemotherapeutic compounds were randomly divided into three groups: treated group Ⅰ, treated group Ⅱ and anemic control group. Intraperitoneal doses of AMI (500 mg/kg, 1000 mg/kg) were given to the treated group, and equal doses of physiological saline were given to the anemic control group. On 7 days after treatment, the count of whole blood cells and bone marrow cells were determined by blood auto-analyzer. The numbers of CFU-GM ( granulocyte and macrophage colony forming unit), CFU-E ( colony forming unit-erythroid), BFU-E ( burst forming unit-erythroid), CFU-Meg(colony forming unit-megakaryocyte) were determined by using technique of hematopoietic progenitor cells culture in vitro. Expression of anti-apoptosis protein BcL-XL and BcL-2 in BMC were determined by immunohistochemistry, Results: RBC,HB,PLT(P 〈 0. 05 ) and BMC ( P 〈 0. 01 )in treated group I were significantly higher than that of anemic control. The number of CFU-E,BFU-E and CFU-Meg as well as expression of anti-apoptosis protein BcL-XL of BMC in treated group Ⅰ also were significantly higher than that of anemic control(P 〈0. 05 or P 〈0. 01 ), while numbers of CFU-E as well as expression of anti-apoptosis protenin BcL-XL of BMC in treated group Ⅱ were higher than that of anemic control( P 〈0. 05). Conclusion: AMI can lesson apoptosis of bone marrow cells and promote hematopoietic progenitor cells to differentiate along the erythroid and megakaryocytoid line by up-regulating expression of antiapoptosis protein BcL-XL of BMC.
出处
《中药材》
CAS
CSCD
北大核心
2005年第9期791-793,共3页
Journal of Chinese Medicinal Materials